Ventus Therapeutics
MA - Waltham
Biotechnology2 H-1B visas (FY2023)Focus: Small Molecules targeting proteins in the inflammasome and nucleic acid sensing signaling pathways
Ventus Therapeutics is a life sciences company focused on Small Molecules targeting proteins in the inflammasome and nucleic acid sensing signaling pathways.
ImmunologyNeurology
Open Jobs
0
Pipeline & Clinical Trials
Provent
Sleep Apnea, ObstructiveClinical Trials (1)
NCT00901771Study of Provent Treatment of Obstructive Sleep Apnea in Patients Who Are Non-compliant With CPAP
N/AExtension Study of Original Protocol AERO C009 for Obstructive Sleep Apnea-hypopnea
Obstructive Sleep Apnea HypopneaClinical Trials (1)
NCT00849043Extension Study of Original Protocol AERO C009 for Obstructive Sleep Apnea-hypopnea
N/ATreatment sleep study
Sleep Apnea, ObstructiveClinical Trials (1)
NCT01061476Sleep Apnea Treatment With Expiratory Resistance(Provent™)
Phase 1/2VENT-02
Parkinson DiseaseClinical Trials (1)
NCT06822517A Phase 1b Study of the NLRP3 Inhibitor VENT-02 in Patients With Mild to Moderate Parkinson's Disease
Phase 1/2Phase 2
Clinical Trials (1)
NCT07260877A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
Phase 2Provent Professional Sleep Apnea Therapy Device
Obstructive Sleep Apnea HypopneaClinical Trials (1)
NCT00772044Randomized Study of Provent Versus Sham Device to Treat Obstructive Sleep Apnea
Phase 4Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 6 clinical trials
H-1B (2023): 2 approvals
Hiring Trend
Stable
0
Open Roles
+0
Added
-0
Filled/Removed
Based on last 4 crawl cycles
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
2
Approved
0
Denied
100%
Rate
Source: USCIS H-1B Employer Data Hub